Australian researchers commence Phase I strep A vaccine trial
Australia
Intravacc enrols first subject in intranasal Covid-19 booster trial
The initial interim data from the trial is anticipated by the end of the first quarter of next year.
Argenica announces first subject dosing in third cohort of ARG-007 trial
Novavax reports Phase III topline data of Omicron subvariant vaccines
Innovent begins subject dosing in Phase I solid tumour therapy trial
Vaxxinity concludes subject enrolment in Phase III Covid-19 vaccine trial
Alterity Therapeutics obtains approval in Australia to begin MSA therapy
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
